skip to main content

We are fortunate to advise world-class, industry-leading companies, helping them tackle novel, complex issues and push the boundaries of technological progress. Our ability and confidence to go to trial is our core strength; our deep bench of experienced trial lawyers represents companies in their most significant matters, helping them protect their intellectual property and launch products. Our lawyers pair extensive experience in the courtroom and the boardroom with a thorough understanding of science and technology.

Paul, Weiss Wins $393 Million Jury Verdict for Edwards Lifesciences in Patent Litigation

As reported in The American Lawyer, Bloomberg News and IP Law360, a federal court jury awarded Paul, Weiss client Edwards Lifesciences $393.6 million after it found that Medtronic Inc.'s CoreValve transcatheter heart valve infringed Edwards' patent.  The jury found the infringement to be willful, which allows Edwards to seek enhanced damages of up to three times the jury award for past infringement.  In addition, Edwards will move for an injunction prohibiting future CoreValve manufacture and sales in the United States. 

The Paul, Weiss team representing Edwards Lifesciences included retired litigation partner John Nathan, litigation partners Catherine Nyarady and Nicholas Groombridge and counsel Kripa Raman.

January 16, 2014

© 2020 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy